Scholar Rock Holding Corp. (SRRK)
49.32
0.00 (0.00%)
USD |
NASDAQ |
Apr 16, 13:47
Scholar Rock Research and Development Expense (Quarterly) : 46.45M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Krystal Biotech, Inc. | 13.23M |
| Stoke Therapeutics, Inc. | 41.29M |
| Biogen, Inc. | 434.00M |
| Eli Lilly & Co. | 3.802B |
| Apellis Pharmaceuticals, Inc. | 74.23M |